An Increase of Plasma Advanced Oxidation Protein Products Levels Is Associated with Cardiovascular Risk in Incident Peritoneal Dialysis Patients: A Pilot Study

Table 1

Clinical and biochemistry values and kidney and peritoneal function parameters in 48 PD patients at inclusion and at one year after starting PD.

	PD patients ()
	Baseline	One year after
BMI, kg/m^2	25 ± 3.3	25.4 ± 3.2
Cholesterol, mg/dL	175 (149–199)	164 (145–187)
Triglycerides, mg/dL	121 (97–188)	107 (85–123)
Albumin, g/dL	3.7 ± 0.4	3.7 ± 0.4
hs-CRP, mg/L	1.5 (0.7–4.7)	1.9 (0.7–3.2)
AOPPs, μmol/L	76.6 (61.4–92.3)	95.2 (75.3–126.3)
Residual diuresis, mL/24 h	1713 ± 1125	1302 ± 945
Residual GFR, mL/min/1.73 m^2	5.9 ± 3.6	4.3 ± 3.4
Creatinine MTAC, mL/min	8.7 ± 2.7	8.7 ± 4.3
Urea MTAC, mL/min	22.4 ± 4.5	22 ± 6.9
Ultrafiltration, mL/4 h (dwell time 3.86% glucose)	708 ± 241	693 ± 265
Peritoneal protein clearance, mL/day	4.7 ± 3.5	4.9 ± 3.8

Values are presented as mean SD for normally distributed variables, or median (interquartile range) for nonnormal data.
BMI: body mass index; hs-CRP: high-sensitivity C-reactive protein; AOPPs: advanced oxidative protein products; GFR: glomerular filtration rate; MTAC: mass transport area coefficient.